Skip to content
Back to Guavy Wire
Stocks

Judi Platform Integrates Microsoft Office for Enhanced Clinical Trial Collaboration

Instruments
MSFT
Share

AG Mednet has integrated Microsoft Office into its clinical trial optimization platform, Judi. This integration allows sponsors, CROs, AROs, sites, and committees to work on familiar Microsoft Office documents within the secure Judi platform.

The drafting stage is now under the same permissions and audit trail as the rest of the study, reducing the risk of accidental PHI exposure. Previously, document authoring took place outside the Judi platform, where sensitive information moved freely and versions multiplied fastest.

According to Abraham Gutman, Founder and CEO, AG Mednet, 'the audit trail in most trials has a gap precisely where the judgment happens.' The Microsoft Office integration closes this gap by capturing the reasoning behind decisions with the same rigor as the results.

Judi's native Microsoft Office integration includes role- and workflow-stage permissions, a full audit trail on every document action, real-time co-authoring, and availability across trial functions. It works seamlessly with a team's existing Microsoft Office license.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc